Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharmaceutical symbols : BXRX save search
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-04-25 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 63.83%
H: 12.66%
C: -32.14%
bx1000 positive trial results phase 2
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
Published: 2023-02-23 (Crawled : 15:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -0.4%
H: 2.38%
C: -11.51%
financial update results
Baudax Bio to Present at the 24th Annual H.C. Wainwright Healthcare Conference
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: -6.24%
conference
Baudax Bio Announces Pricing of $10.0 Million Public Offering - Feb 25, 2022
Published: 2022-02-25 (Crawled : 09:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -46.37%
H: 0.0%
C: 0.0%
offering ces
Baudax Bio Announces Clinical Program Update for Neuromuscular Blocking Agents BX-1000, BX-2000 and BX-3000
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 3.48%
H: 0.22%
C: -5.73%
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.94 84.57% 1.4M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.